These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15505010)

  • 1. Postabsorptive and insulin-stimulated energy homeostasis and leucine turnover in offspring of type 2 diabetic patients.
    Lattuada G; Sereni LP; Ruggieri D; Scollo A; Benedini S; Ragogna F; Costantino F; Battezzati A; Luzi L; Perseghin G
    Diabetes Care; 2004 Nov; 27(11):2716-22. PubMed ID: 15505010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM.
    Luzi L; Petrides AS; De Fronzo RA
    Diabetes; 1993 Dec; 42(12):1868-77. PubMed ID: 8243833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: is cellular insulin resistance a secondary phenomenon?
    Eriksson JW; Smith U; Waagstein F; Wysocki M; Jansson PA
    Diabetes; 1999 Aug; 48(8):1572-8. PubMed ID: 10426375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients.
    Luzi L; Perseghin G; Brendel MD; Terruzzi I; Battezzati A; Eckhard M; Brandhorst D; Brandhorst H; Friemann S; Socci C; Di Carlo V; Piceni Sereni L; Benedini S; Secchi A; Pozza G; Bretzel RG
    Diabetes; 2001 Feb; 50(2):277-82. PubMed ID: 11272137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1.
    Perseghin G; Comola M; Scifo P; Benedini S; De Cobelli F; Lanzi R; Costantino F; Lattuada G; Battezzati A; Del Maschio A; Luzi L
    Am J Clin Nutr; 2004 Aug; 80(2):357-64. PubMed ID: 15277156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Energy metabolism in diabetic and nondiabetic heart transplant recipients.
    Benedini S; Fiocchi R; Battezzati A; Scifo P; Sereni LP; Gamba A; Mammana C; Del Maschio A; Perseghin G; Luzi L
    Diabetes Care; 2002 Mar; 25(3):530-6. PubMed ID: 11874942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.
    Vauhkonen I; Niskanen L; Vanninen E; Kainulainen S; Uusitupa M; Laakso M
    J Clin Invest; 1998 Jan; 101(1):86-96. PubMed ID: 9421470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin effect on leucine kinetics in type 2 diabetes mellitus.
    Halvatsiotis PG; Turk D; Alzaid A; Dinneen S; Rizza RA; Nair KS
    Diabetes Nutr Metab; 2002 Jun; 15(3):136-42. PubMed ID: 12173727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased insulin-stimulated ATP synthesis and phosphate transport in muscle of insulin-resistant offspring of type 2 diabetic parents.
    Petersen KF; Dufour S; Shulman GI
    PLoS Med; 2005 Sep; 2(9):e233. PubMed ID: 16089501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients.
    Castellino P; Luzi L; Giordano M; Defronzo RA
    J Am Soc Nephrol; 1999 May; 10(5):1050-8. PubMed ID: 10232692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of glucose in the regulation of glutamine metabolism in health and in type 1 insulin-dependent diabetes.
    Hankard RG; Haymond MW; Darmaun D
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E608-13. PubMed ID: 10950829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: effects of acute insulin withdrawal.
    Moller N; Jensen MD; Rizza RA; Andrews JC; Nair KS
    Diabetologia; 2006 Aug; 49(8):1901-8. PubMed ID: 16718465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals.
    Pendergrass M; Bertoldo A; Bonadonna R; Nucci G; Mandarino L; Cobelli C; Defronzo RA
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E92-100. PubMed ID: 16896161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin and amino acids on leucine metabolism in young and middle-aged humans.
    Luzi L; Giordano M; Caloni ; Castellino P
    Eur J Nutr; 2001 Jun; 40(3):106-12. PubMed ID: 11697442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective suppression by insulin of leucine-carbon appearance and oxidation in type 1, insulin-dependent diabetes mellitus. Evidence for insulin resistance involving glucose and amino acid metabolism.
    Tessari P; Nosadini R; Trevisan R; De Kreutzenberg SV; Inchiostro S; Duner E; Biolo G; Marescotti MC; Tiengo A; Crepaldi G
    J Clin Invest; 1986 Jun; 77(6):1797-804. PubMed ID: 3519679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin and fibrinogen synthesis and insulin effect in type 2 diabetic patients with normoalbuminuria.
    Tessari P; Kiwanuka E; Millioni R; Vettore M; Puricelli L; Zanetti M; Gucciardi A; Tosolini M; Cogo P; Carnielli V; Tiengo A; Barazzoni R
    Diabetes Care; 2006 Feb; 29(2):323-8. PubMed ID: 16443881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients.
    Lattuada G; Costantino F; Caumo A; Scifo P; Ragogna F; De Cobelli F; Del Maschio A; Luzi L; Perseghin G
    Diabetologia; 2005 Apr; 48(4):741-7. PubMed ID: 15759111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine metabolism in type II diabetes mellitus.
    Staten MA; Matthews DE; Bier DM
    Diabetes; 1986 Nov; 35(11):1249-53. PubMed ID: 3530853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.